Clinical Trial Update: Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

View source ↗

Summary

This clinical trial is studying serum DCAMKL1 levels before and after treatment in patients with pancreatic cancer; the study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Oklahoma | Conditions: Pancreatic Cancer | Status: ACTIVE_NOT_RECRUITING